Tactile Systems Technology Inc. (NASDAQ:TCMD) is one of the best stocks for beginners with little money in 2026. On February 17, Tactile Systems Technology delivered financial results for 2025, with total revenue rising 12% to $329.5 million. The company concluded the year with a robust cash position of $83.4 million.
During this period, the company acquired Lymphotec to target the large population of undiagnosed lymphedema patients. By integrating Lymphotec’s fluid-monitoring tech into its commercial engine, Tactile aims to enhance patient surveillance and streamline the path to therapy. The CEO noted that 2024 investments in a new CRM system and expanded sales headcount are now driving productivity gains. Additionally, updated Medicare National Coverage Determination criteria have provided a tailwind by allowing certain patients to access the FlexiTouch system more directly.
A medical technician holding the instruments in her hands
Despite the positive momentum, Tactile Systems Technology Inc. issued a balanced outlook for 2026, projecting revenue growth of 8% to 11%. This guidance accounts for a potential short-term headwind: a new Medicare prior authorization requirement for pneumatic compression devices.
Tactile Systems Technology Inc. is a medical technology company that develops and provides medical devices to treat underserved chronic diseases in the US.
READ NEXT: 10 Most Profitable Undervalued Stocks to Buy and 11 Best Mining Stocks to Buy According to Wall Street.
